Department of Radiology, University of Cambridge School of Clinical Medicine.
Dr Jonathan Birchall received his PhD from the University of Nottingham in 2017, researching experimental methods for improving 129Xe hyperpolarisation with an application to clinical functional lung imaging. He continued in a postdoctoral role for one year, performing QA/QC duties for the clinical Hyperpolarised Imaging Lung Facility (HILF), before moving to Wayne State University, Detroit, USA to take up a postdoctoral role developing pre-clinical hyperpolariser technologies for 13C, 15N and 129Xe.
He joined the University of Cambridge as a Research Associate in the Gallagher Group, where his goals are to develop novel screening techniques for cancer using pre-clinical hyperpolarised 13C-MRI, with aim towards evaluation, documentation and eventual translation of these techniques into human imaging. This work is jointly funded by the University and The National Cancer Imaging Translational Accelerator (NCITA), where he is a member of the QA/QC Unit responsible for developing Standard Operating Procedures and performing data analysis on NCITA exemplar studies towards the creation of an MRI Core Lab.